Correction to: Trends in Use of Sulfonylurea Types Among US Adults with Diabetes: NHANES 1999-2020.
Correction to: Trends in Use of Sulfonylurea Types Among US Adults with Diabetes: NHANES 1999-2020.
复制标题
更正：美国成人糖尿病患者使用磺酰脲类药物的趋势：NHANES 1999-2020。
DOI：
10.1007/s11606-023-08445-4
复制
发表时间：
2023
影响因子：
5.7
通讯作者：
Selvin,Elizabeth
中科院分区：
文献类型：
--
作者：
Shin,Jung-Im;Echouffo-Tcheugui,JustinB;Fang,Michael;Grams,MorganE;Selvin,Elizabeth
图1在发表的论文中没有正确复制，修改后的图如下：（图中所示。）磺脲类药物在美国成年糖尿病患者中的使用趋势，NHANES 1999 - 2020阴影区域表示95%置信区间。第一代磺酰脲类药物包括氯磺丙脲和甲磺脲。
Figure 1 in the published paper did not reproduce correctly, the revised figure is below:(Figure presented.) Trends in sulfonylurea use among US adults with diagnosed diabetes, NHANES 1999 to 2020. Shaded areas indicate 95% confidence intervals. First-generation sulfonylurea includes chlorpropamide and tolazamide.